ArticleAmerican journal of translational research2017

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Zheng Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.